T1	Intervention 64 172	diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen
T2	Intervention 860 990	receive a single oral dose of either one FDC tablet or co-administration of two separate diflunisal and naproxen marketed tablets.
T3	Intervention 991 1139	Plasma samples were obtained over a 72-h interval and analyzed for diflunisal and naproxen by reversed phase liquid chromatography with UV detection
